|
RXCentric and MedPanel Partner to Provide Pharmaceutical Market Research Services
Combined Offering Provides Greater Speed, Efficiency and Broader Physician NetworkNEW YORK, NY -- DECEMBER 14, 2000 -- RxCentric (www.rxcentric.com), a leading Internet marketing solutions provider to the pharmaceutical industry, and MedPanel (www.medpanel.com), a provider of online medical research and marketing services, announced today that they have entered into an agreement to provide pharmaceutical companies enhanced online market research capabilities.
"Today, speed to market based on informed decision-making, increasingly distinguishes the leaders in the pharmaceutical market," said Richard Findlay, RxCentric's President and Chief Executive Officer. "Our partnership with MedPanel harnesses the power of MedPanel's network of medical opinion leaders from top academic medical centers worldwide, RxCentric's network of 20,000 community-based physician users, and both companies' leading edge Internet solutions. These together will provide our clients with valued research guidance and in-depth exposure at greater speed and considerably less cost than has ever before been possible," added Findlay. Through this agreement, both companies will promote each other's products and services to their existing clients, as well as to new and potential clients. "The pharmaceutical marketplace is rapidly adopting new Internet-based methodologies to facilitate communication with physicians so as to dramatically improve research and marketing results," said Will Febbo, Chief Executive Officer of MedPanel. "The online research capabilities now offered to pharmaceutical companies through this agreement will allow our clients to leverage the knowledge and opinions of both academic and community physicians to enhance and accelerate their feasibility studies, product development cycles, marketing programs and research efforts."
About RxCentricRxCentric is a leading e-health company leveraging the power of the Internet to link physicians' drug information and education needs with a unique, targeted online pharmaceutical product-marketing capability. RxCentric provides its 20,000 registered only physician users customized information in seven targeted medical specialties through its free, physician-only Internet Service Provider, Doctors Net Access (DNA): Allergy, Cardiology, Neurology, Oncology/Hematology, Primary Care, Pulmonary Medicine and Urology. In addition to the specialty medical channels, RxCentric's suite of online pharmaceutical sales and marketing products includes online detailing, market research, drug sampling, continuing medical education (CME), online events and more. RxCentric is a privately held company with offices in New York City and Hawthorne, NY. RxCentric's current pharmaceutical partners include some of the world's largest pharmaceutical companies.
About MedPanel, Inc.MedPanel offers an innovative service that brings focus groups and advisory board activities online in a threaded discussion format, providing advantages over traditional market research methodologies. MedPanel's large key opinion leader database and its online masked participation allows for geographic dispersity without the travel, encouraging participation from experts that would otherwise not be willing or able to participate.
Founded in 1999, MedPanel works with pharmaceutical, biotechnology and medical device companies and the marketing, communications agencies, and financial groups who support them. Clients include Aventis, Bayer AG, Boston Scientific Corporation, GlaxoSmithKline, GelTex Pharmaceuticals, Hollister Inc., Eli Lilly and Company, Millennium Pharmaceuticals, and Pfizer Inc.
MedPanel is a privately held company headquartered in Cambridge, Massachusetts.
Contact: Erin Sheehan 617-661-8080 x29
www.MedPanel.com